<DOC>
	<DOCNO>NCT01570101</DOCNO>
	<brief_summary>The primary objective clinical study assess role CE Marked Sapheon Closure System closure incompetent great saphenous vein `` GSV '' routine clinical setting .</brief_summary>
	<brief_title>European Sapheon™ Closure System Observational ProspectivE ( eSCOPE ) Study</brief_title>
	<detailed_description>This post market , observational study closure great saphenous vein `` GSV '' . Efficacy safety ( adverse event ) compare appropriate literature report determine result treatment reflux disease Sapheon Closure System consistent good expectation medical community alternative treatment , specifically Laser Thermal Ablation Radiofrequency Ablation . Additional comparison point may include measurement pain and/or length time return work .</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<criteria>Age ≥18 year ≤ 70 year age . Symptomatic primary Great Saphenous Vein `` GSV '' incompetence diagnose clinical symptom , without visible varicosity , confirm duplex ultrasound image . CEAP classification C2 , C3 C4 . Ability walk unassisted . Ability attend followup visit . Ability understand requirement study provide write informed consent . `` GSV '' stand preprocedure Doppler Ultrasound ≥3mm ≤10mm ( maximum diameter ) . Life expectancy &lt; 1 year . Regular pain medication . Anticoagulation include Heparin Coumadin . Previous Deep Vein Thrombosis `` DVT '' . Previous superficial thrombophlebitis `` GSV '' . Previous venous treatment target limb . Known Hypercoagulable disorder . Conditions prevent routine vein treatment like : Acute disease , Immobilization inability ambulate , Pregnancy . Tortuous `` GSV '' , opinion Investigator limit catheter placement . ( 2 primary access site allow ) . Incompetent ipsilateral small saphenous anterior accessory great saphenous vein . Known sensitivity cyanoacrylate `` CA '' adhesive . Current participation another clinical study involve investigational agent treatment , within 30 day prior enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>